The hepatic encephalopathy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Hepatic Encephalopathy Market, 2024 report by The Business Research Company
offers comprehensive insights into the current state of the market and
highlights future growth opportunities.
Market Size -
The hepatic encephalopathy market size has grown strongly in recent years. It
will grow from $1.62 billion in 2023 to $1.72 billion in 2024 at a compound
annual growth rate (CAGR) of 6.0%. The growth in the historic period can be
attributed to prevalence of liver diseases, growing awareness about hepatic
encephalopathy, government initiatives, increasing new liver therapies.
The hepatic encephalopathy market size is expected to see strong growth in the
next few years. It will grow to $2.1 billion in 2028 at a compound annual
growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed
to increasing ageing population, surge in treatment options, rising expenditure
on healthcare infrastructure, investments on hepatic encephalopathy treatments.
Major trends in the forecast period include launch of emerging therapies,
research and clinical trials, advances in liver transplantation, pharmaceutical
innovations, advances in nutrition and dietary management, adption of
telemedicine and remote monitoring.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report
Scope Of Hepatic Encephalopathy Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Hepatic Encephalopathy Market Overview
Market Drivers -
The growing prevalence of liver diseases is expected to propel the growth of
the hepatic encephalopathy market going forward. Liver disease is a medical
condition affecting the liver and impairing its function. Liver disease
treatments such as hepatic encephalopathy can alleviate symptoms, slow disease
progression, improve liver function and reduce hepatic encephalopathy
occurrences by improving the management of underlying conditions, potentially
reducing frequency and severity and enhancing patients' overall quality of
life. For instance, in March 2023, according to the Office For Health
Improvement And Disparities, a UK-based government organization, premature
deaths from liver disease increased by 3.7% in 2021 from 10,501 to 10,127 in
2020. Therefore, the growing prevalence of liver diseases drives the hepatic
encephalopathy market.
Market Trends -
Major companies operating in the hepatic encephalopathy market are developing
innovative drugs to treat hepatic encephalopathy to gain competitive advantages
and strengthen their position in the market. For instance, in June 2023,
Karolinska Development AB, a Sweden-based pharmaceutical company, developed the
novel GR3027 (golexanolone) to treat hepatic encephalopathy. This is an orally
administered small molecule and a GABAA-receptor-modulating steroid antagonist
(GAMSA) designed to antagonize positive GABAA-receptor modulation by endogenous
neuroactive steroids. Additionally, the drug is being investigated for HE. The
trial is being conducted for CHE in Phases I/IIa.
The hepatic encephalopathy market covered in this report is segmented –
1) By Drug Class: Antibiotics; Laxatives; L-Ornithine; L-Aspartate; Other Drug
Classes
2) By Route Of Administration: Oral; Intravenous; Rectal
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online
Pharmacies
Get an inside scoop of the hepatic encephalopathy market, Request now for
Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12906&type=smp
Regional Insights -
North America was the largest region in the hepatic encephalopathy market in
2023. The regions covered in hepatic encephalopathy market report are
Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East and Africa.
Key Companies -
Major players in the hepatic encephalopathy market are Umecrine Cognition AB,
Bausch Health Companies Inc., Mallinckrodt Pharmaceuticals, Lupin Limited,
Salix Pharmaceuticals, Norgine B.V., Ferring B.V., ASKA Pharmaceutical Co.
Ltd., Vedanta Biosciences Inc., Gilead Sciences Inc., Amgen Inc., Teva
Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc.,
Ochsner Health Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's
Laboratories Ltd., Cipla Limited, Amneal Pharmaceuticals LLC, Mallinckrodt PLC,
Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., ASKA
Pharmaceutical Co. Ltd., Norgine B.V.
Table of Contents
1. Executive Summary
2. Hepatic Encephalopathy Market Report Structure
3. Hepatic Encephalopathy Market Trends And Strategies
4. Hepatic Encephalopathy Market – Macro Economic Scenario
5. Hepatic Encephalopathy Market Size And Growth
…..
27. Hepatic Encephalopathy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment